These effects, along with a prior report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the idea of focusing on ACKR3 as a unique technique to modulate the opioid program, which could open new therapeutic avenues for opioid-linked Issues. These success recommend that conolidine https://annieo848ruq1.hyperionwiki.com/user